Wenlening^® (Telmisartan and Hydrochlorothiazide Tablets) is a fixed-dose compound preparation composed of telmisartan and hydrochlorothiazide, primarily used for the treatment of essential hypertension. It is a mainstream compound antihypertensive drug recommended by authoritative guidelines both domestically and internationally. This product has passed the Generic Drug Consistency Evaluation.

Primary Indications

Indicated for the treatment of hypertension to lower blood pressure.

The Main Contraindication To Medication

Contraindications include:  

1. Hypersensitivity to the active substance or any excipients of this product;  

2. Hypersensitivity to other sulfonamide derivatives (since hydrochlorothiazide is a sulfonamide derivative);  

3. Prohibited for use during the second and third trimester of pregnancy, and lactation period;  

4. Cholestatic diseases and biliary obstructive diseases;  

5. Severe hepatic impairment and severe renal impairment;  

6. Refractory hypokalemia and hypercalcemia.

Dosage Form

Tablets